Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis

European Journal of Gastroenterology and Hepatology

Volumn 28, Issue 4, 2016, Pages 444-448

  Cheng, Xiang Pu ^a   Zhao, Jing ^a   Chen, Yu ^a   Meng, Fan Kun ^a   Xu, Bin ^a   Yu, Hong Wei ^a   Meng, Qing Hua ^a   Liu, Yan Min ^a   Zhang, Shi Bin ^a   Meng, Sha ^a   Zhang, Jing Yun ^a   Zhang, Jin Yan ^a   Duan, Zhong Ping ^a   Zheng, Su Jun ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Child Turcotte Pugh score; Cirrhosis; Hepatitis B virus; Indocyanine green; Model for end stage liver disease; Model for end stage liver disease with serum sodium concentration; Pulse dye densitometry

Indexed keywords

INDOCYANINE GREEN; SODIUM; BIOLOGICAL MARKER; COLORING AGENT;

ADULT; ANALYZER; ARTICLE; CHILD PUGH SCORE; COHORT ANALYSIS; DECOMPENSATED LIVER CIRRHOSIS; DIAGNOSTIC TEST ACCURACY STUDY; DRUG CLEARANCE; END STAGE LIVER DISEASE; FEMALE; HEPATITIS B; HUMAN; INDOCYANINE GREEN CLEARANCE TEST; INTERMETHOD COMPARISON; LABORATORY TEST; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PULSE DYE DENSITO GRAPH ANALYZER; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SODIUM BLOOD LEVEL; SURVIVAL RATE; SURVIVOR; AGED; AREA UNDER THE CURVE; BLOOD; COMPARATIVE STUDY; COMPLICATION; DECISION SUPPORT SYSTEM; LIVER TRANSPLANTATION; MIDDLE AGED; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; PROSPECTIVE STUDY; REPRODUCIBILITY; RISK FACTOR; VIROLOGY;

AGED; AREA UNDER CURVE; BIOMARKERS; COLORING AGENTS; DECISION SUPPORT TECHNIQUES; FEMALE; HEPATITIS B; HUMANS; INDOCYANINE GREEN; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; ROC CURVE; SODIUM;

EID: 84949456104     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000538     Document Type: Article

References (24)

1. Murphy SL, Xu J, Kochanek KD. Deaths: final data for 2010. Natl Vital Stat Rep 2013; 61:1-117.
2. Caesar J, Shaldon S, Chiandussi L, Guevara L, Sherlock S. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci 1961; 21:43-57.
3. Fan ST. Methods and related drawbacks in the estimation of surgical risks in cirrhotic patients undergoing hepatectomy. Hepatogastroenterology 2002; 49:17-20.
4. Merle U, Sieg O, Stremmel W, Encke J, Eisenbach C. Sensitivity and specificity of plasma disappearance rate of indocyanine green as a prognostic indicator in acute liver failure. BMC Gastroenterol 2009; 9:91.
5. Sakka SG, Reinhart K, Meier-Hellmann A. Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients. Chest 2002; 122:1715-1720.
6. Pan Z, Wu XJ, Li JS, Liu FN, Li WS, Han JM. Functional hepatic flow in patients with liver cirrhosis. World J Gastroenterol 2004; 10:915-918.
7. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60:646-649.
8. Huo TI, Lee SD, Lin HC. Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond. Liver Int 2008; 28:606-613.
9. Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006; 130:1652-1660.
10. Bambha K, Kim WR, Kremers WK, Therneau TM, Kamath PS, Wiesner R, et al. Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements. Am J Transplant 2004; 4:1798-1804.
11. Botta F, Giannini E, Romagnoli P, Fasoli A, Malfatti F, Chiarbonello B, et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut 2003; 52:134-139.
12. Hori T, Iida T, Yagi S, Taniguchi K, Yamamoto C, Mizuno S, et al. K(ICG) value, a reliable real-time estimator of graft function, accurately predicts outcomes in adult living-donor liver transplantation. Liver Transpl 2006; 12:605-613.
13. Díaz S, Pérez-Peña J, Sanz J, Olmedilla L, Garutti I, Barrio JM. Haemodynamic monitoring and liver function evaluation by pulsion cold system Z-201 (PCS) during orthotopic liver transplantation. Clin Transplant 2003; 17:47-55.
14. Faybik P, Krenn CG, Baker A, Lahner D, Berlakovich G, Steltzer H, Hetz H. Comparison of invasive and noninvasive measurement of plasma disappearance rate of indocyanine green in patients undergoing liver transplantation: a prospective investigator-blinded study. Liver Transpl 2004; 10:1060-1064.
15. Sheng QS, Lang R, He Q, Yang YJ, Zhao DF, Chen DZ. Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis. Hepatobiliary Pancreat Dis Int 2009; 8:46-49.
16. Cholongitas E, Marelli L, Shusang V, Senzolo M, Rolles K, Patch D, Burroughs AK. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl 2006; 12:1049-1061.
17. Feng HL, Li Q, Wang L, Yuan GY, Cao WK. Indocyanine green clearance test combined with MELD score in predicting the short-term prognosis of patients with acute liver failure. Hepatobiliary Pancreat Dis Int 2014; 13:271-275.
18. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464-470.
19. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31:864-871.
20. Reuben A. Child comes of age. Hepatology 2002; 35:244-245.
21. Angermayr B, Cejna M, Karnel F, Gschwantler M, Koenig F, Pidlich J, et al. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 2003; 52:879-885.
22. Zipprich A, Steudel N, Behrmann C, Meiss F, Sziegoleit U, Fleig WE, Kleber G. Functional significance of hepatic arterial flow reserve in patients with cirrhosis. Hepatology 2003; 37:385-392.
23. Klinzing S, Brandi G, Stehberger PA, Raptis DA, Béchir M. The combination of MELD score and ICG liver testing predicts length of stay in the ICU and hospital mortality in liver transplant recipients. BMC Anesthesiol 2014; 14:103.
24. Zipprich A, Kuss O, Rogowski S, Kleber G, Lotterer E, Seufferlein T, et al. Incorporating indocyanin green clearance into the model for end stage liver disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis. Gut 2010; 59:963-968.